Literature DB >> 6802226

Trimethoprim resistance in hospitals.

P Huovinen, R Mäntyjärvi, P Toivanen.   

Abstract

During November 1980 to April 1981, 1561 urinary tract pathogens were collected from Turku City Hospital, Turku University Central Hospital, and Kuopio University Central Hospital. Resistance of the strains was tested by agar-plate dilution against trimethoprim, sulphamethoxazole-trimethoprim, sulphamethoxazole, ampicillin, and nitrofurantoin. Resistance to trimethoprim (greater than 8 mg/l) occurred in 8.6-12.2% of strains from the university hospitals (Pseudomonas excluded) and 38.3% of strains from Turku City Hospital. Resistance of Escherichia coli occurred in 4.1-6.2% of strains from the university hospitals and 21% of strains from Turku City Hospital. Proteus mirabilis was the most resistant of the clinically important bacterial species with resistance to trimethoprim in 29-78%. Attention is called for in defining the type of hospital used for a particular study: bacterial resistance in different hospitals cannot be compared direct and one hospital is not necessarily representative for a whole country. After seven years' use of plain trimethoprim the prevalence of resistance in the two university hospitals in Finland was similar to that in a London hospital just before plain trimethoprim was registered for use in Britain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802226      PMCID: PMC1496373          DOI: 10.1136/bmj.284.6318.782

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  7 in total

1.  Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections.

Authors:  A Kasanen; M Anttila; R Elfving; P Kahela; H Saarimaa; H Sundquist; R Tikkanen; P Toivanen
Journal:  Ann Clin Res       Date:  1978

2.  Identification of gram-negative aerobic fermentors in a clinical bacteriological laboratory.

Authors:  A A Lindberg; C E Nord; M Hellgren; L Sjöberg
Journal:  Med Microbiol Immunol       Date:  1974-03-22       Impact factor: 3.402

3.  [Resistance determination of bacteria: new classification in sensitive groups--S, I and R].

Authors:  K Alestig; K Dornbusch; C Ericson; L O Kallings; C Kamme; F Nordbring; R Norrby; G Wallmark
Journal:  Lakartidningen       Date:  1978-11-22

4.  R-factor mediated trimethoprim resistance: result of two three-month clinical surveys.

Authors:  S G Amyes; A M Emmerson; J T Smith
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

5.  Resistance to trimethoprim in 1978-79 compared with 1973-75.

Authors:  J M Hamilton-Miller; A Gooding; W Brumfitt
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

6.  Trimethoprim resistance in Finland.

Authors:  H E Busk; B Korner
Journal:  Br Med J       Date:  1980-04-12

7.  Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens.

Authors:  K Dornbusch; P Toivanen
Journal:  Scand J Infect Dis       Date:  1981
  7 in total
  7 in total

Review 1.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  High-level trimethoprim resistance in urinary bacteria.

Authors:  S G Amyes; C J Doherty; H K Young
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

4.  Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984.

Authors:  P Huovinen; L Pulkkinen; H L Helin; M Mäkilä; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

5.  Characterization of trimethoprim resistance by use of probes specific for transposon Tn7.

Authors:  L Pulkkinen; P Huovinen; E Vuorio; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

6.  Emergence of trimethoprim resistance in fecal flora.

Authors:  P Huovinen; T Mattila; O Kiminki; L Pulkkinen; S Huovinen; M Koskela; R Sunila; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.